Oncology Drug Screening Services
Rapidly screen promising immuno-oncology targets; Sengenics helps accelerate oncology drug discovery with fast and efficient screening of immunotherapy drug targets.
-
Most popular related searches
Improving p53 Screening
The p53 tumor suppressor protein is a DNA binding protein. Wild type and mutated versions of p53 are important targets for immuno-oncology drug development.
Our OncoRex p53 Cancer Array provides a biologically relevant screening tool since all p53 variants are correctly folded and functional using our patented KREX® protein folding technology. Using our array, we can screen your therapeutic antibodies and protein binding compounds against more than 100 p53 wildtype and mutant variants by measuring their impact on DNA binding as a functional readout.
Customer reviews
No reviews were found for Oncology Drug Screening Services. Be the first to review!